Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Qwaqwa Campus announces 2017/2018 SRC
2017-09-06

Description: QQ campus SRC Tags: Qwaqwa Campus, SRC,Sasco, Prakash Naidoo 

Newly-elected SRC President, Masopha Hlalele, leading a
ceremonial walk to the SRC chambers for the first sitting
of the SRC.With him is the Director: Student Affairs,
Temba Hlasho;IEA Chairperson, Grey Magaiza; and
Campus Principal, Prof Prakash Naidoo.
Photo: Thabo Kessah


The 2017/2018 Student Representative Council (SRC) elections on the Qwaqwa Campus of the University of the Free State (UFS) have been declared free, fair, and credible. This was announced by the Chairperson of the institutional Independent Electoral Agency (IEA), Grey Magaiza, during the official announcement of the results and the hand-over ceremony held on 4 September 2017. 

“We had an average voter turnout of 52% per elective portfolio, thus making it arguably one of the highest in the country. Compared to last year, there was a 15% increase notwithstanding the 23% increase in the student population,” he said.  
In congratulating the newly-elected SRC, the Director of Student Affairs, Temba Hlasho, challenged the student leaders to leave the campus intact and fully sustainable for future generations.
“You are now faced with the mammoth task of understanding your role in developing an ethical and moral leadership that will help to sustain the university academically, financially, and beyond.”
In his response, the new SRC President, Masopha Hlalele, acknowledged the role played by the previous SRC, and said they were prepared to usher in a new phase of turning each student into a proud ambassador of the campus.

“We will be ushering in a new phase where all students will be the focus of the SRC. This will be a phase where students will not discriminate against each other, but appreciate each other’s differences and become ambassadors,” he said.

The South African Students’ Congress (Sasco) won all seven elective seats with an average of 62.5%.

Elective portfolios:

President: Masopha Hlalele 
Deputy President: Sakhile Mnguni 
Secretary General:  Mawande Mazibuko 
Treasurer General:  Mafusi Mosia 
Media and Publicity:  Khethukuthula Thusi 
Student Development and Environmental Affairs: Mbali Ndlovu 
Politics and Transformation: Promise Mofokeng

Ex officio portfolios:

Arts and Culture: Khulani Mhlongo 
Religious Affairs: Ndamulelo Muthaki, 
RAG, Community and Dialogue: Mafeka Tshabalala 
Residence and Catering Affairs: Thato Moloi  
Sports Affairs: Sibusiso Nsibande
Academic Affairs: Mamokete Tamo
Off-Campus: Khethwa Mngezi 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept